KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson’s Disease

Monoamine oxidase-B (MAO-B) is a well-established therapeutic target for Parkinson’s disease (PD); however, previous clinical studies on currently available irreversible MAO-B inhibitors have yielded disappointing neuroprotective effects. Here, we tested the therapeutic potential of KDS2010, a recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Min-Ho, Park, Jong-Hyun, Song, Hyo Jung, Choi, Ji Won, Kim, Siwon, Jang, Bo Ko, Yoon, Hyung Ho, Heo, Jun Young, Lee, Hyowon, An, Heeyoung, Kim, Hyeon Jeong, Park, Sun Jun, Cho, Doo-Wan, Yang, Young-Su, Han, Su-Cheol, Kim, Sangwook, Oh, Soo-Jin, Jeon, Sang Ryong, Park, Ki Duk, Lee, C. Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608967/
https://www.ncbi.nlm.nih.gov/pubmed/34611843
http://dx.doi.org/10.1007/s13311-021-01097-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608967/
https://www.ncbi.nlm.nih.gov/pubmed/34611843
http://dx.doi.org/10.1007/s13311-021-01097-4

Ejemplares similares